We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TPG:NASDAQTPG Inc. Analysis

Data as of 2026-05-05 - not real-time

$45.82

Latest Price

8/10Risk

Risk Level: High

Executive Summary

TPG Inc. trades at a trailing P/E of 99.6×, far above the asset‑management industry average of 17.5×, while its forward P/E contracts to about 12.9×, suggesting the market is pricing in a steep earnings rebound. The stock currently yields 4.97% with a modest forward payout ratio of 9%, but operating cash flow is zero and the company carries a high debt‑to‑equity of 62.9, raising questions about dividend sustainability. Technicals show a bullish MACD crossover, an RSI of 62 indicating momentum, and price sitting near the upper band of its 37.14 support and 46.89 resistance range, while the 30‑day volatility of 39% and beta of 1.6 point to a high‑risk profile. Recent news highlights a record capital‑raising year exceeding $50 billion and a 36% YoY increase in fee‑related earnings, underpinning a forward earnings outlook that could justify the current valuation. Analysts have raised target prices to the mid‑$50s, implying an upside of roughly 20% from the current level of $45.8. However, the company’s negative operating margin (‑31.8%) and a max drawdown of ‑45% over recent periods temper enthusiasm, especially for long‑term holders.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD and momentum reflected in RSI above 60
  • Upcoming earnings release expected to beat consensus
  • Attractive dividend yield relative to peers

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward P/E compression to ~13× indicating earnings growth
  • Capital formation strength and 36% fee‑related earnings growth
  • Analyst consensus target price around $55 providing ~20% upside

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High valuation multiples and volatile price history
  • Sustainable dividend concerns due to zero operating cash flow
  • Strong asset‑management franchise with continued capital raising

Key Metrics & Analysis

Financial Health

Revenue Growth-54.80%
Profit Margin4.23%
P/E Ratio99.6
ROE10.76%
ROA3.16%
Debt/Equity62.90
P/B Ratio6.2
Industry P/E17.5

Technical Analysis

TrendNeutral
RSI62.4
Support$37.14
Resistance$46.89
MA 20$42.91
MA 50$41.96
MA 200$54.92
MACDBullish
VolumeStable
Fear & Greed Index90.66

Valuation

Target Price$54.88
Upside/Downside19.78%
GradeFair
TypeBlend
Dividend Yield4.97%

Risk Assessment

Beta1.61
Volatility39.23%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.